MOBILIZE Trademark

Trademark Overview


On Friday, November 14, 2025, a trademark application was filed for MOBILIZE with the United States Patent and Trademark Office. The USPTO has given the MOBILIZE trademark a serial number of 99497178. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Friday, November 14, 2025. This trademark is owned by Fapon Halobio (Shenzhen) Co., Ltd.. The MOBILIZE trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Scientific and technological services, namely, scientific research in the field of biotechnology, pharmaceuticals, genetic medicine, and cell therapy, namely, design, research, development, and testing of targeted drug delivery platforms; Research and development in the field of universal, modular, and cell-specific nanoparticle delivery systems for the in vivo delivery of therapeutic agents and for the in vivo engineering and modification of cells, said therapeutic agents and agents for cell modification including nucleic acids such as mRNA, circRNA, siRNA, and gene editing components; Pharmaceutical research in the field of oncology, immunology, neurology, genetic diseases, and regenerative medicine; Technology consultation and research in the field of licensing of intellectual property for the development and commercial-scale manufacturing of targeted therapeutic agents and cell therapy products; Providing scientific research information in the field of personalized medicine
mobilize

General Information


Serial Number99497178
Word MarkMOBILIZE
Filing DateFriday, November 14, 2025
Status630 - NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
Status DateFriday, November 14, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Indication of Colors claimedColor is not claimed as a feature of the mark.
Goods and ServicesScientific and technological services, namely, scientific research in the field of biotechnology, pharmaceuticals, genetic medicine, and cell therapy, namely, design, research, development, and testing of targeted drug delivery platforms; Research and development in the field of universal, modular, and cell-specific nanoparticle delivery systems for the in vivo delivery of therapeutic agents and for the in vivo engineering and modification of cells, said therapeutic agents and agents for cell modification including nucleic acids such as mRNA, circRNA, siRNA, and gene editing components; Pharmaceutical research in the field of oncology, immunology, neurology, genetic diseases, and regenerative medicine; Technology consultation and research in the field of licensing of intellectual property for the development and commercial-scale manufacturing of targeted therapeutic agents and cell therapy products; Providing scientific research information in the field of personalized medicine
Description of MarkThe mark consists of The wording "MOBILIZE" in a stylized font. The letter "O" has the outline of a circle centered within it, and one small kite-shaped quadrilateral to the top left and one small kite-shaped quadrilateral to the bottom right.
Translation of Words in MarkMobilize has no meaning in a foreign language.

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, November 14, 2025
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameFapon Halobio (Shenzhen) Co., Ltd.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressShenzhen, Guangdong 518000
CN

Trademark Events


Event DateEvent Description
Friday, November 14, 2025NEW APPLICATION ENTERED
Friday, November 14, 2025APPLICATION FILING RECEIPT MAILED